metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Caracterización de Escherichia coli de los grupos filogenéticos A y B1 causant...
Journal Information
Vol. 24. Issue 8.
Pages 483-489 (October 2006)
Share
Share
Download PDF
More article options
Vol. 24. Issue 8.
Pages 483-489 (October 2006)
Originales
Full text access
Caracterización de Escherichia coli de los grupos filogenéticos A y B1 causantes de infección extraintestinal
Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection
Visits
12219
Eva Moreno, Guillem Prats, Irene Planells, Ana M. Planes, Teresa Pérez, Antonia Andreu
Corresponding author
anandreu@vhebron.net

Correspondencia: Dra. A. Andreu. Servicio de Microbiología. Hospital Vall d’Hebron. P.° Vall d’Hebron, 119-129. 08035 Barcelona. España.
Servicio de Microbiología. Hospital Vall d’Hebron. Universidad Autónoma de Barcelona. España
This item has received
Article information
Introducción

Escherichia coli de los grupos filogenéticos no patógenos A y B1 raramente causan infecciones extraintestinales. El objetivo de este estudio es el de caracterizar 37 E. coli de los grupos filogenéticos A y B1 y compararlos con 37 E. coli del grupo B2 y 31 del grupo D, productores de las mismas infecciones.

Métodos

De estos 105 casos de E. coli aislados de orina de pacientes con cistitis y pielonefritis y de sangre de pacientes con sepsis urinaria y de otros orígenes, se estudió el grupo filogenético, 15 genes de virulencia, los antígenos O asociados a infección extraintestinal y la sensibilidad a fluoroquinolonas.

Resultados

Los aislados de E. coli de los grupos A/B1 presentaron menos determinantes de virulencia (media de 3,5) que los del grupo B2 (8,6; p<0,001) y D (5,3; p<0,001); sin embargo un subgrupo formado por 3 aislados del grupo A y 5 del B1 poseían 5 o más factores. E. coli de los grupos A/B1 se asociaron con frecuencia significativa a resistencia a fluoroquinolonas (74%; p<0,001), mientras que los del grupo B2 se asociaron a sensibilidad (76%; p=0,003). E. coli de los grupos A/B1 se aislaron de forma significativa en pacientes con pielonefritis y sepsis y factores favorecedores de infección, asociación que no se observó en pacientes con cistitis.

Conclusión

E. coli de los grupos filogenéticos A y B1, a pesar de que en general presentan un bajo potencial patógeno, se han mostrado capaces de producir infecciones extraintestinales, especialmente en pacientes con factores favorecedores de infección.

Palabras clave:
Escherichia coli
Factores de virulencia
Grupo filogenético A y B1
Infección extraintestinal
Introduction

Escherichia coli isolates from the non-pathogenic phylogenetic groups A and B1 rarely cause extraintestinal infections. The aim of this study was to analyze 37 E. coli isolates pertaining to phylogenetic groups A and B1 and compare them with 37 E. coli isolates from group B2 and 31 from group D, which caused the same infections.

Methods

Among 105 E. coli isolated from the urine of patients with cystitis and pyelonephritis and from the blood of patients with urinary-source and other-source bacteriemia, the E. coli phylogenetic groups, 15 virulence-associated genes, 7 O-antigens and fluoroquinolone resistance were analyzed.

Results

E. coli from groups A and B1 showed fewer virulence determinants (median 3.5) than E. coli from group B2 (8.6, P <.001) or D (5.3, P <.001); however, a subgroup containing 3 isolates from group A and 5 from B1 harbored 5 o more factors. E. coli from groups A/B1 were associated with resistance to fluoroquinolones (74%, P <.001), whereas E. coli from group B2 were associated with susceptibility to this antibiotic (76%, P =.003). E. coli from groups A/B1 were isolated significantly more frequently in patients with pyelonephritis or sepsis and local or general factors favoring infection, association not observed in patients with cystitis.

Conclusions

Even though most of the E. coli isolates from phylogenetic groups A and B1 presented a low virulence potential, they were able to cause extraintestinal infections, particularly in compromised patients.

Key words:
Escherichia coli
Virulence factors
Phylogenetic group A and B1
Extraintestinal infection
Full text is only aviable in PDF
Bibliografía
[1.]
K.A. Bettelheim.
Escherichia coli in the normal flora of humans and animals.
Escherichia coli: mechanisms of virulence, 1st ed., pp. 85-109
[2.]
P.J. Herzer, S. Inouye, M. Inouye, T.S. Whittam.
Phylogenetic distribution of branched RNS-linked multicopy single-stranded DNA among natural isolates of Escherichia coli.
J Bacteriol, 172 (1990), pp. 6175-6181
[3.]
B. Picard, J. Sevali, S. Gouriou, P. Duriez, N. Brahimi, E. Bingen, et al.
The link between phylogeny and virulence in Escherichia coli extraintestinal infection.
Infect Immun, 67 (1999), pp. 546-553
[4.]
R.K. Selander, T.K. Korhonen, V. Väisänen-Rhen, P.H. Williams, P.E. Pattison, D.A. Caugant.
Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis.
Infect Immun, 52 (1986), pp. 213-222
[5.]
T.A. Russo, J.R. Johnson.
Proposal of a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.
J Infect Dis, 181 (2000), pp. 1753-1754
[6.]
J.R. Johnson, M.A. Kuskowski, T.T. O’Bryan, J.N. Maslow.
Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia.
J Clin Infect, 185 (2002), pp. 1439-1447
[7.]
J.R. Johnson, A.L. Stell.
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.
J Infect Dis, 181 (2000), pp. 261-272
[8.]
G. Lecointre, L. Rachdi, P. Dariu, E. Denamur.
Escherichia coli molecular phylogeny using the incongruence length difference test.
Mol Biol Evol, 15 (1998), pp. 1685-1695
[9.]
P. Duriez, O. Clermont, S. Bonacorsi, E. Bingen, A. Chaventré, J. Elion, et al.
Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations.
Microbiol, 174 (2001), pp. 1671-1676
[10.]
E. Moreno, I. Planells, G. Prats, A.M. Planes, G. Moreno, A. Andreu.
Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia vs. strains causing pyelonephritis and other sources of bacteremia.
Diagn Microbiol Infec Dis, 53 (2005), pp. 93-99
[11.]
E. Moreno, G. Prats, M. Sabaté, T. Pérez, J.R. Johnson, A. Andreu.
Quinolone, fluoroquinolone, and trimethoprim-sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
J Antimicrob Chemoth, 57 (2006), pp. 204-211
[12.]
O. Clermont, S. Bonacorsi, E. Bingen.
Rapid and simple determination of the Escherichia coli phylogenetic group.
App Envir Microbiol, 66 (2000), pp. 4555-4558
[13.]
A. Andreu, A.E. Stapleton, C. Fenell, M. Xercavins, H.A. Lockman, W.E. Stamm.
Uroviulence determinants in Escherichia coli strains causing prostatitis.
J Infect Dis, 176 (1997), pp. 464-469
[14.]
M. Blanco, J. Blanco, J.E. Blanco, M.P. Alonso, I. Abalia, E. Rodriguez, et al.
Factores de virulencia y serogrupos O de Escherichia coli causantes de infecciones urinarias comunitarias.
Enferm Infecc Microbiol Clin, 13 (1995), pp. 236-241
[15.]
National Committee for Clinical Laboratory Standards. Perfomance standards for antimicrobial susceptibility testing. Fourteenth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA, 2004.
[16.]
J.R. Johnson, T.T. O’Bryan, M. Kuskowski, J.N. Maslow.
Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.
Infect Immun, 69 (2001), pp. 5363-5374
[17.]
E. Bingen, B. Picard, N. Brahimi, S. Mathy, P. Desjardins, J. Elion, et al.
Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggest horizontal transfer from a predominant pool of highly virulent B2 group strains.
J Infect Dis, 177 (1998), pp. 642-650
[18.]
J.R. Johnson, A. Gajewski, A.J. Lesse, T.A. Russo.
Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infection.
J Clin Microb, 41 (2003), pp. 5798-5802
[19.]
J. Johnson, M.A. Kuskowski, A. Gajewski, S. Soto, J.P. Horcajada, M. Jiménez de Anta, et al.
Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis.
J Infect Dis, 191 (2005), pp. 46-50
[20.]
J.R. Johnson, M. Kuskowski, E. Denamur, J. Elion, B. Picard.
Clonal origin, virulence factors, and virulence.
Infect Immun, 68 (2000), pp. 424-425
[21.]
J.R. Johnson, M.A. Kuskowski, T.T. O’Bryan, R. Colodner, R. Raz.
Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from israeli women with acute uncomplicated cystitis.
Antimicrob Agents Chem, 49 (2005), pp. 26-31
[22.]
M.R. Sannes, M.A. Kuskowski, K. Owens, A. Gajewski, J.R. Johnson.
Virulence factor profile and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects.
J Clin Dis, 190 (2004), pp. 2121-2128
[23.]
J.R. Johnson, M.A. Kuskowski, A. Gajewski, D.F. Sahm, J.A. Karlowsky.
Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.
J Infect Dis, 190 (2004), pp. 1739-1744
[24.]
Begel S, Heisig P, Wiedemann B. Fluoroquinolone resistance of Escherichia coli frequently is associated with decreased expression of type 1 fimbriae. Proceedings of the 37th Interscience Conference on Antimicrobial and Chemotherapy; 1997 Toronto, Canada. American Society for Microbiology. Washington, DC. 1997. p. 52.
[25.]
L. Martínez-Martínez, F. Fernández, E.J. Perea.
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
J Antimicrob Chem, 43 (1999), pp. 277-279
[26.]
J. Vila, K. Simon, J. Ruiz, J.P. Horcajada, M. Velasco, M. Barranco, et al.
Are quinolone-resistant uropathogenic Escherichia coli less virulent?.
J Infect Dis, 186 (2002), pp. 1039-1044
[27.]
S.M. Soto, M.T. Jiménez de Anta, J. Vila.
Quinolones induce partial or total loss of pathonicity islands in uropathogenic Escherichia coli by SOS-dependent or independent pathways, respectively.
Antimicrob Agents Chemother, 50 (2006), pp. 649-653
[28.]
J.P. Horcajada, S. Soto, A. Gajewski, A. Smithson, M.T. Jiménez de Anta, J. Mensa, et al.
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.
J Clin Microbiol, 43 (2005), pp. 2962-2964
[29.]
J.R. Johnson, S. Moseley, P. Roberts, W.E. Stamm.
Aerobactina and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics.
Infect Immun, 56 (1988), pp. 405-412
[30.]
J.R. Johnson, P. Goullet, B. Picard, S.L. Moseley, P.L. Roberts, W.E. Stamm.
Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis.
Infect Immun, 59 (1991), pp. 2311-2315
[31.]
J.R. Johnson, I. Orskov, F. Orskov, P. Goullet, B. Picard, S.L. Moseley, et al.
O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli causing urosepsis.
J Infect Dis, 169 (1994), pp. 119-129
[32.]
J.R. Johnson, P.L. Roberts, W.E. Stamm.
P fimbriae and other virulence factors in Escherichia coli urosepsis: association with patient's characteristics.
J Infect Dis, 156 (1987), pp. 225-229
[33.]
E. Moreno, A. Andreu, T. Pérez, M. Sabaté, J.R. Johnson, G. Prats.
Relationships between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts.
Epidemiol Infect, 26 (2006), pp. 1-9
Copyright © 2006. Elsevier España S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos